P3 Health Partners Inc. (PIII) vs Quantum BioPharma Ltd. (QNTM)

A side-by-side comparison of P3 Health Partners Inc. and Quantum BioPharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PIII vs QNTM

growth of $100 · dividends reinvested · last 5y
PIII -98.7% (-58.2%/yr)QNTM -97.4% (-51.8%/yr)QNTM compounded faster over this window
050100Start $10020222023202420252026$1$3
PIII QNTM

PIII vs QNTM: by the numbers

  • •QNTM is the larger company ($21M vs $20M market cap).
  • •Both run net losses; QNTM's is the smaller (0.00% vs -6.55% net margin).

Metrics side by side

Valuation

MetricPIIIQNTM
P/S ratio0.01N/A
P/B ratioN/A2.71

Profitability

MetricPIIIQNTM
Gross margin-9.89%0.00%
Operating margin-18.53%0.00%
Net margin-6.55%0.00%
ROE-136.36%-313.46%
ROIC-51.68%-27.14%

Growth (annualized)

MetricPIIIQNTM
Revenue CAGR (5Y)22.04%N/A
Total return CAGR (5Y)-58.41%-49.16%

Frequently asked

How have PIII and QNTM total returns compared?
Over the past 5 years, PIII delivered -58.41% and QNTM delivered -49.16% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.